IP Verse

Progranulin For Use In Treating Parkinson'S Disease Or Alzheimer'S Disease - EP3009143

The patent EP3009143 was granted to Neurodyn Life Sciences on Oct 3, 2018. The application was originally filed on Jan 16, 2009 under application number EP15194111A. The patent is currently recorded with a legal status of "Revoked".

EP3009143

NEURODYN LIFE SCIENCES
Application Number
EP15194111A
Filing Date
Jan 16, 2009
Status
Revoked
Jul 7, 2023
Publication Date
Oct 3, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

CMS CAMERON MCKENNA NABARRO OLSWANGJul 3, 2019CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE
MATHYS & SQUIREJul 2, 2019WILDINGADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2006252705
DESCRIPTIONUS4713249
DESCRIPTIONUS5266333
DESCRIPTIONUS5417982
DESCRIPTIONUS6333194
DESCRIPTIONUS7105342
DESCRIPTIONUS7112668
OPPOSITIONEP2687223
OPPOSITIONUS2005123962
OPPOSITIONWO2007146046
OPPOSITIONWO2008019187
OPPOSITIONWO2008079187
OPPOSITIONWO2009010045
SEARCHWO2007146046
SEARCHWO2008019187
SEARCHWO2009010045

Non-Patent Literature (NPL) Citations (40) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- CASHMAN ET AL., DEV DYN, (1992), vol. 194, no. 3, pages 209 - 221
DESCRIPTION- CASHMAN ET AL., DEV DYN., (1992), vol. 194, pages 209 - 21
DESCRIPTION- ROY ET AL., J EUROSCI., (1998), vol. 18, pages 9673 - 9684
DESCRIPTION- ROY ET AL., J. NEUROSCI., (1998), vol. 18, pages 9673 - 9684
DESCRIPTION- ROY ET AL., J. NEUROSCI., vol. 18, pages 9673 - 9684
DESCRIPTION- SHAW, NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, (2003), vol. 27, page 493
DESCRIPTION- TABATA ET AL., NEUROMOLECULAR MED, (2008), vol. 10, no. 1, pages 24 - 39
DESCRIPTION- TOLKATCHEV D ET AL., PROTEIN SCI., (2008), vol. 17, pages 711 - 724
DESCRIPTION- VAN DAMME, J CELL BIOL, (2008), vol. 181, no. 1, pages 37 - 41
DESCRIPTION- WILSON ET AL., NEUROMOLECULAR MEDICINE, (2003), vol. 3, pages 105 - 118
DESCRIPTION- WILSON, NEUROIMAGE, (2004), vol. 23, pages 336 - 343
DESCRIPTION- ZHENG ET AL., IN VITRO CELL DEV BIOL ANIM., (2007), vol. 43, no. 5-6, pages 155 - 158
OPPOSITION- Anonymous, "Somatic mutation", Britannica Online Encyclopedia, (20190626), page 1, URL: https://www.britannica.com/science/somatic-mutation, XP055619983
OPPOSITION- BERNARD KHOO et al., "Antisense oligonucleotide-induced alternative splicing of the APOB mRNA generates a novel isoform of APOB", BMC Molecular Biology 2007, (20070000), vol. 8, no. 3, XP002486383
OPPOSITION- MIMOUN AZZOUZ, "Gene Therapy for ALS: Progress and prospects", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, (20061100), vol. 1762, no. 11-12, pages 1122 - 1127, XP055620016
OPPOSITION- SIEGERS [SLEEGERS] K et al., "Progranulin modifies onset age and survival in amyotrophic lateral sclerosis", Neurology, (20070000), vol. 68, no. 12, pages A202 - A202, XP008140330
OPPOSITION- GIRONI et al., "Multiple Sclerosis and Neurodegenerative Diseases", (20160000), pages 63 - 84, XP055621333
OPPOSITION- KLEIN et al., "Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model", Neurosci Lett., (20060619), vol. 401, no. 1-2, doi:doi:10.1016/j.neulet.2006.03.001, pages 130 - 135, XP025023811
OPPOSITION- BAKER et al., "Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17", Nature, (20060824), vol. 442, doi:doi:10.1038/NATURE05016, pages 916 - 919, XP008101482
OPPOSITION- CRUTS et al., "Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21", Nature, (20060000), vol. 442, doi:doi:10.1038/NATURE05017, pages 920 - 924, XP008101481
OPPOSITION- CRUTS M et al., "Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21", Nature, (20060824), vol. 442, doi:doi:10.1038/NATURE05017, pages 920 - 924, XP008101481
OPPOSITION- ZHIHENG HE et al., "Progranulin is a mediator of the wound response", Nature Medicine, (20030000), vol. 9, no. 2, doi:doi:10.1038/nm816, XP055032993
OPPOSITION- ZHIHENG HE et al., "Progranulin is a mediator of the wound response", Nature Medicine, (20030113), vol. 9, no. 2, doi:doi:10.1038/nm816, ISSN 1078-8956, pages 225 - 229, XP055032993
OPPOSITION- LO BIANCO et al., "Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an a-synuclein rat model of Parkinson's disease", PNAN, (20041214), vol. 101, no. 50, pages 17510 - 17515, XP002677073
OPPOSITION- PHILIP VAN DAMME et al., "Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival", Journal of Cell Biology, (20080407), vol. 181, no. 1, doi:doi:10.1083/jcb.200712039, pages 37 - 41, XP008140331
OPPOSITION- VAN DAMME, P. et al., "Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival", J. Cell Biol., vol. 181, no. 1, doi:doi:10.1083/jcb.200712039, (20080407), pages 37 - 41, (20080331), XP008140331
OPPOSITION- J. S. SNOWDEN et al., "Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia", Brain, vol. 129, no. 11, (20060900), pages 3091 - 3102, URL: https://doi.org/10.1093/brain/awl267, XP055620005
OPPOSITION- SNOWDEN et al., "Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia", Brain, (20060900), vol. 129, no. 11, doi:10.1093/brain/awl267, ISSN 0006-8950, pages 3091 - 3102, XP055620005
OPPOSITION- MICHEL GOEDERT et al., "Frontotemporal lobar degeneration through loss of progranulin function", Brain, vol. 129, no. 11, (20061100), pages 2808 - 2810, URL: https://doi.org/10.1093/brain/awl291, XP055620009
OPPOSITION- VOSSEL KA et al., "New approaches to the treatment of frontotemporal lobar degeneration", Curr Opin Neurol., (20080000), vol. 21, no. 6, pages 708 - 716, XP055620001
OPPOSITION- DE TOMMASO et al., "Pain in Neurodegenerative Disease: Current Knowledge and Future perspectives", Hindawi Publishing Corporation - Behavioural Neurology, (20160000), vol. 2016, pages 1 - 14, XP055621332
OPPOSITION- LARS BERTRAM et al., "The genetic epidemiology of neurodegenerative disease", J Clin Invest., vol. 115, no. 6, (20050000), pages 1449 - 1457, URL: https://doi.org/10.1172/JCI24761, XP055619988
OPPOSITION- JAN STENVANG et al., "MicroRNAs as targets for antisense-based therapeutics", Expert Opinion on Biological Therapy, vol. 8, no. 1, doi:doi:10.1517/14712598.8.1.59, (20071217), pages 59 - 81, XP009163100
OPPOSITION- YONG-JIE ZHANG et al., "Progranulin Mediates Caspase-Dependent Cleavage of TAR DNA Binding Protein-43", JNeurosci The Journal of Neuroscience, (20070000), vol. 27, no. 39, doi:doi:10.1523/JNEUROSCI.3421-07.2007, pages 10530 - 10534, XP008140333
OPPOSITION- EVA BIANCONI et al., "An estimation of the number of cells in the human body", Annals of Human Biology, (20130000), vol. 40, no. 6, pages 463 - 471, XP055619972
SEARCH- CRUTS M ET AL, "Progranulin mutations in Ubiquitin-positive frontotemporal dementia linked to Chromosome 17q21", CURRENT ALZHEIMER RESEARCH, BENTHAM SCIENCE PUBL. LTD, NL, (20060101), vol. 3, no. 5, ISSN 1567-2050, pages 485 - 491, XP008140332 [A] 1-15 * abstract *
SEARCH- SIEGERS K ET AL, "Progranulin modifies onset age and survival in Amyotrophic Lateral Sclerosis", NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, PHILADELPHIA, US, (20070320), vol. 68, no. 12, SU, ISSN 0028-3878, page A202, XP008140330 [A] 1-15 * abstract *
SEARCH- ZHIHENG HE ET AL, "Progranulin is a mediator of the wound response", NATURE MEDICINE, (20030201), vol. 9, no. 2, doi:10.1038/nm816, ISSN 1078-8956, pages 225 - 229, XP055032993 [X] 9,11-15 * page 228, left column, paragraph 3 * * abstract *
SEARCH- PHILIP VAN DAMME ET AL, "Progranulin functions as a neurotrophic factor to regulate neurite outgrowth and enhance neuronal survival", THE JOURNAL OF CELL BIOLOGY : JCB, THE ROCKEFELLER UNIVERSITY PRESS, US, (20080407), vol. 181, no. 1, doi:10.1083/JCB.200712039, ISSN 0021-9525, pages 37 - 41, XP008140331 [XP] 1-15 * abstract *
SEARCH- YONG-JIE ZHANG ET AL, "Progranulin mediates caspase-dependent cleavage of TAR DNA Binding Protein-43", JOURNAL OF NEUROSCIENCE, THE SOCIETY, WASHINGTON, DC, US, (20070926), vol. 27, no. 39, doi:10.1523/JNEUROSCI.3421-07.2007, ISSN 1529-2401, pages 10530 - 10534, XP008140333 [A] 1-15 * abstract *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents